This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2015 Sep 23:351:h4897.

doi: 10.1136/bmj.h4897.

The FDA's new clothes

Donald W Light¹, Joel Lexchin²

Affiliations

Affiliations

¹ School of Osteopathic Medicine, Rowan University, 2250 Chapel Avenue, Cherry Hill, NJ 08002, USA dlight@rowan.edu.
² School of Health Policy and Management, York University, 4700 Keele Street, Toronto, ON M3J 1P3, Canada.

PMID: 26399468
DOI: 10.1136/bmj.h4897

Editorial

The FDA's new clothes

Donald W Light et al. BMJ. 2015.

. 2015 Sep 23:351:h4897.

doi: 10.1136/bmj.h4897.

Authors

Donald W Light¹, Joel Lexchin²

Affiliations

¹ School of Osteopathic Medicine, Rowan University, 2250 Chapel Avenue, Cherry Hill, NJ 08002, USA dlight@rowan.edu.
² School of Health Policy and Management, York University, 4700 Keele Street, Toronto, ON M3J 1P3, Canada.

PMID: 26399468
DOI: 10.1136/bmj.h4897

No abstract available

PubMed Disclaimer

Comment on

Characteristics of efficacy evidence supporting approval of supplemental indications for prescription drugs in United States, 2005-14: systematic review.
Wang B, Kesselheim AS. Wang B, et al. BMJ. 2015 Sep 23;351:h4679. doi: 10.1136/bmj.h4679. BMJ. 2015. PMID: 26400844 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- HighWire